6472 — Bora Pharmaceuticals Co Share Price
0.000.00%
Last trade - 00:00- TWD71.44bn
- TWD75.72bn
- TWD14.20bn
- 96
- 27
- 59
- 69
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 19.13 | ||
| PEG Ratio (f) | 1.15 | ||
| EPS Growth (f) | 19.95% | ||
| Dividend Yield (f) | 2.15% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 7.86 | ||
| Price to Tang. Book | 20.48 | ||
| Price to Free Cashflow | 22.15 | ||
| Price to Sales | 5.03 | ||
| EV to EBITDA | 12.93 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 31.2% | ||
| Return on Equity | 44.52% | ||
| Operating Margin | 36.97% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | TWDm | 1,529.22 | 1,799.57 | 4,899.89 | 10,494.47 | 14,200.07 | 16,795.71 | 21,870.2 | 59.57% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +71.34 | -38.07 | +269.45 | +82.77 | +108.62 | +15.05 | +29.71 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Bora Pharmaceuticals Co Ltd is a Taiwan-based company principally engaged in the agency and sales of western medicines, as well as the research, development, manufacture and sales of new drugs and health products. The Company's main products are categorized into prescription drugs and health care products, including central nervous drugs, cardiovascular drugs, antibiotics, antiviral agents, ophthalmic drugs, gastrointestinal drugs, foam ingots and health care products. In addition, the Company has biopharmaceutical technologies related to the development of cell lines for the production of protein drugs, the development and analysis of upstream and downstream processes, as well as the establishment of quality control and testing specifications and the creation of cell banks.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- June 12th, 2007
- Public Since
- October 1st, 2014
- No. of Employees
- 91
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Taiwan Stock Exchange
- Shares in Issue
- 101,192,128
- Address
- 6F, No.69, Xing'ai Road, Neihu District, TAIPEI, 114
- Web
- https://www.bora-corp.com/
- Phone
- +886 227901555
- Auditors
- Ernst & Young LLP
Upcoming Events for 6472
Q2 2024 Bora Pharmaceuticals Co Ltd Earnings Release
Similar to 6472
Adimmune
Taiwan Stock Exchange
China Chemical & Pharmaceutical Co
Taiwan Stock Exchange
Chunghwa Chemical Synthesis & Biotech Co
Taiwan Stock Exchange
Formosa Laboratories
Taiwan Stock Exchange
Lotus Pharmaceutical Co
Taiwan Stock Exchange
FAQ
What is the Bora Pharmaceuticals Co share price?
As of Today at 19:04 UTC, shares in Bora Pharmaceuticals Co are trading at TWD706.00. This share price information is delayed by 15 minutes.
How has the Bora Pharmaceuticals Co share price performed this year?
Shares in Bora Pharmaceuticals Co last closed at TWD706.00 and the price had moved by +16.23% over the past 365 days. In terms of relative price strength the Bora Pharmaceuticals Co share price has outperformed the FTSE Developed Asia Pacific Index by +21.31% over the past year.
What are the analyst and broker recommendations for Bora Pharmaceuticals Co?
The overall consensus recommendation for Bora Pharmaceuticals Co is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Bora Pharmaceuticals Co dividend yield?
The Bora Pharmaceuticals Co dividend yield is 1.7% based on the trailing twelve month period.
Does Bora Pharmaceuticals Co pay a dividend?
Last year, Bora Pharmaceuticals Co paid a total dividend of TWD12.00, and it currently has a trailing dividend yield of 1.7%. We do not have any data on when Bora Pharmaceuticals Co is to next pay dividends.
When does Bora Pharmaceuticals Co next pay dividends?
We do not have data on when Bora Pharmaceuticals Co is to next pay dividends. The historic dividend yield on Bora Pharmaceuticals Co shares is currently 1.7%.
How do I buy Bora Pharmaceuticals Co shares?
To buy shares in Bora Pharmaceuticals Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Bora Pharmaceuticals Co?
As of the previous close price of TWD706.00, shares in Bora Pharmaceuticals Co had a market capitalisation of TWD71.44bn.
Where are Bora Pharmaceuticals Co shares listed?
Here are the trading details for Bora Pharmaceuticals Co:
- Country of listing: Taiwan
- Exchange: TAI
- Ticker Symbol: 6472
What kind of share is Bora Pharmaceuticals Co?
Based on an overall assessment of its quality, value and momentum Bora Pharmaceuticals Co is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Bora Pharmaceuticals Co share price forecast for 2024?
The analyst consensus target price for shares in Bora Pharmaceuticals Co is TWD897.33. That is 27.1% above the last closing price of TWD706.00.
Analysts covering Bora Pharmaceuticals Co currently have a consensus Earnings Per Share (EPS) forecast of TWD33.85 for the next financial year.
What is the trend in the Bora Pharmaceuticals Co share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Bora Pharmaceuticals Co. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +16%.
As of the last closing price of TWD706.00, shares in Bora Pharmaceuticals Co were trading +7.77% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Bora Pharmaceuticals Co PE Ratio?
The Bora Pharmaceuticals Co PE ratio based on its reported earnings over the past 12 months is 19.13. The shares last closed at TWD706.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Bora Pharmaceuticals Co?
We do not have data on Bora Pharmaceuticals Co's directors